Category: Biosimilars
Biosimilars market research reports by The Business Research Company
-
Bevacizumab Biosimilars Global Market Report 2024
Bevacizumab Biosimilars Global Market Report 2024 Including: 1) By Product: Avastin; Mvasi; Zirabev; Aybintio2) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy3) By Application: Colorectal Cancer; Non-small Cell Lung Cancer; Glioblastoma; Renal Cell Carcinoma; Cervical C ... Read More
-
Biosimilar Therapeutic Peptides Global Market Report 2024
Biosimilar Therapeutic Peptides Global Market Report 2024 Including: 1) By Type: Innovative; Generic2) By Route Of Administration: Parenteral Route; Transdermal Route 3) By Application: Cancer; Cardiovascular; Central Nervous Systems; Metabolic Disorders; Infection; Hematological Disorders; Gastroin ... Read More
-
Trastuzumab Biosimilars Global Market Report 2024
Trastuzumab Biosimilars Global Market Report 2024 Including: 1) By Product: Ogivri; Herzuma; Ontruzant; Trazimera2) By Indication: Adjuvant Breast Cancer; Metastatic Breast Cancer; Metastatic Gastric Cancer3) By Distribution Channel: Hospital Pharmacy; Online Pharmacy Covering: Pfizer Inc.; Outlook ... Read More
-
Oral Biologics & Biosimilars Global Market Report 2024
Oral Biologics & Biosimilars Global Market Report 2024 Including: 1) By Therapy: Lymphocyte Modulators; Interleukin Inhibitors; Tumor Necrosis Factor-Alpha Inhibitors; Immunostimulants; GPCR Modulators 2) By Disease: Diabetes; Arthritis and Crohn’s Disease; Cancer; Infectious Disease Autoimmune Dise ... Read More
-
Rituximab Biosimilars Global Market Report 2024
Rituximab Biosimilars Global Market Report 2024 Including: 1) By Route Of Administration: Subcutaneous; Intravenous; Molecular Type 2) By Application: Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia; Rheumatoid Arthritis 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Mail Orde ... Read More
-
Pegfilgrastim Biosimilars Global Market Report 2024
Pegfilgrastim Biosimilars Global Market Report 2024 Including: 1) By Application: Chemotherapy Treatment; Transplantation 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Mail-Order Pharmacies Covering: Coherus BioSciences; Sandoz; Biocon/Mylan; Intas Biopharmaceuticals Ltd; Mund ... Read More
-
Filgrastim Biosimilars Global Market Report 2024
Filgrastim Biosimilars Global Market Report 2024 Including: 1) By Type Of Manufacturing: In-House Manufacturing; Contract Manufacturing organization 2) By Application: Oncology; Chronic And Autoimmune Diseases; Blood Disorders; Growth Hormone Deficiency 3) By Distribution Channel: Hospital Pharmacy; ... Read More
-
Biosimilars Global Market Report 2024
Biosimilars Global Market Report 2024 Including: 1) By Type: Monoclonal Antibodies; Insulin; Erythropoietin; Granulocyte-Colony Stimulating Factor 2) By Product: Recombinant Non-glycosylated Proteins; Recombinant Glycosylated Proteins 3) By Application: Oncology; Chronic And Autoimmune Diseases; Gr ... Read More
-
Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2024
Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2024 Including: 1) By Product: Adalimumab Biosimilars; Infliximab Biosimilars; Cipleumab 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies 3) By Application: Crohn’s Disease; Psoriatic Arthriti ... Read More
-
Oral Biologics & Biosimilar Drugs Global Market Report 2024
Oral Biologics & Biosimilar Drugs Global Market Report 2024 Including: 1) By Therapy: Lymphocyte Modulators; Interleukin Inhibitors; Tumor Necrosis Factor-Alpha Inhibitors2) By Disease: Asthma; Crohn's Disease; Carcinoma; Arthritis; Diabetes; Multiple Myeloma; Enterocolitis; Multiple Sclerosis; Sarc ... Read More
-
Biosimilar Growth Hormones Global Market Report 2024
Biosimilar Growth Hormones Global Market Report 2024 Including: 1) By Route Of Administration: Intravenous; Subcutaneous; Intramuscular; Oral 2) By Application: Growth Hormone Deficiency; Turner Syndrome; Idiopathic Short Stature; Prader Willi Syndrome 3) By Distribution Channel: Hospital And Retail ... Read More
-
Biosimilar Monoclonal Antibodies Global Market Report 2024
Biosimilar Monoclonal Antibodies Global Market Report 2024 Including: 1) By Type: Synthetic Chemicals; Biopharmaceuticals2) By Compound: Infliximab; Rituximab; Abciximab; Trastuzumab; Adalimumab; Bevacizumab3) By Application: Chronic & Autoimmune Diseases; Oncology Covering: Pfizer Inc.; Novartis AG ... Read More
-
Biosimilar Interleukins Global Market Report 2024
Biosimilar Interleukins Global Market Report 2024 Including: 1) By Type: IL-17; IL-23; IL-1; IL-5; IL-62) By Application: Psoriasis; Psoriatic Arthritis; Rheumatoid Arthritis; Asthma; Inflammatory Bowel Disease (IBD)3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacie ... Read More
-
Oncology Biosimilars Global Market Report 2024
Oncology Biosimilars Global Market Report 2024 Including: 1) By Drug Type: Monoclonal Antibody; Immunomodulators; Hematopoietic Agents; Granulocyte Colony-Stimulating Factor (G-CSF) 2) By Cancer Type: Breast Cancer; Colorectal Cancer; Blood Cancer; Neutropenia Cancer; Non-Small Cell Lung Cancer 3) B ... Read More
-
Biosimilar Hormones Global Market Report 2024
Biosimilar Hormones Global Market Report 2024 Including: 1) By Type: Teriparatide Biosimilars; Follitropin Alfa Biosimilars; Insulin Biosimilars; Somatropin Biosimilars2) By Application: Research & Biotechnology; Diagnostics; Biocatalysts; Therapeutics 3) By Distribution Channel: Hospital And Retail ... Read More
-
Biosimilar Lymphocyte Modulator Global Market Report 2024
Biosimilar Lymphocyte Modulator Global Market Report 2024 Including: 1) By Drug: Campath-1H; Natalizumab Biosimilar; Efalizumab - A1089-Anti-CD11a Biosimilar; Anti-CD38 Daratumumab Biosimilar; Anti-CS1 Elotuzumab Biosimilar 2) By Disease: Arthritis; Diabetes; Multiple Myeloma; Enterocolitis; Multipl ... Read More
-
Insulin biosimilars Global Market Report 2024
Insulin biosimilars Global Market Report 2024 Including: 1) By Biosimilars Type: Rapid Acting biosimilars; Long Acting biosimilars; Premixed Acting biosimilars2) By Disease Indication Type: Type I Diabetes; Type II Diabetes3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Ph ... Read More
-
Glycomic Therapeutics Global Market Report 2023 Including: 1) By Class: Isolated; Synthetic 2) By Structures: Glycoproteins; Targeting Sialic Acid; Proteoglycans; Targeting Glycosaminoglycans; Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans; Targeting Glycosphingolipids 3) By Mode Of Action: Inhibits Neuraminidase; Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate; Erythropoietin And Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 And 3; Beta And Gamma Interferons 4) By Indications: Thrombosis And Chemoprophylaxis; Anemia; Anti-Adhesive And Anti-Inflammatory; Cataracts; Gaucher’s Disease; Mps-1 And IV; Cancer; Alzheimer’s Disease; Influenza Type A And B Covering: F Hoffmann-La Roche Ltd.; Bayer AG; Sanofi SA; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc
Glycomic Therapeutics Global Market Report 2023 Including: 1) By Class: Isolated; Synthetic2) By Structures: Glycoproteins; Targeting Sialic Acid; Proteoglycans; Targeting Glycosaminoglycans; Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans; Targeting Glycosphingolipids ... Read More
-
Remicade Biosimilar Global Market Report 2023 Including: 1) By Type: 100mg/10ml; 500mg/50ml 2) By Disease Indication: Ulcerative Colitis; Rheumatoid Arthritis; Ankylosing Spondylitis; Crohn’s Disease; Psoriatic Arthritis; Plaque Psoriasis 3) By Application: Blood Disorders; Oncology Diseases Covering: AbbVie Inc.; Novartis AG; Amgen Inc; Viatris Inc.; Teva Pharmaceutical Industries Ltd.
Remicade Biosimilar Global Market Report 2023 Including: 1) By Type: 100mg/10ml; 500mg/50ml2) By Disease Indication: Ulcerative Colitis; Rheumatoid Arthritis; Ankylosing Spondylitis; Crohn’s Disease; Psoriatic Arthritis; Plaque Psoriasis3) By Application: Blood Disorders; Oncology DiseasesCovering: ... Read More
-
Ankylosing Spondylitis Global Market Report 2023 Including: 1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Disease-Modifying Anti-Rheumatic Drugs (DMARDS); Biological Therapies; Steroids; Physical Therapies; Surgery 2) By Molecule: Biologics; Biosimilar; Small Molecules 3) By Route of Administration: Parenteral; Oral 4) By Application: Juveniles; Adults 5) By End User: Hospitals; Clinics; Research Laboratoriesrs Covering: Pfizer Inc.; Johnson & Johnson Pvt. Ltd.; Merck & Co. Inc.; AbbVie Inc.; Novartis AG
Ankylosing Spondylitis Global Market Report 2023 Including: 1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Disease-Modifying Anti-Rheumatic Drugs (DMARDS); Biological Therapies; Steroids; Physical Therapies; Surgery2) By Molecule: Biologics; Biosimilar; Small M ... Read More
-
Adalimumab, Infliximab And Etanercept Biosimilars Global Market Opportunities And Strategies To 2031
Adalimumab, Infliximab And Etanercept Biosimilars Global Market Opportunities And Strategies To 2031 Adalimumab, Infliximab And Etanercept Biosimilars Global Market Opportunities And Strategies To 2031 from The Business Research Company provides the strategists; marketers and senior management with ... Read More
-
Oncology Biosimilars Market Global Briefing 2022
Oncology Biosimilars Market Global Briefing 2022 The global oncology biosimilars market grew from $1965.84 million in 2015 to $8319.35 million in 2021 at a compound annual growth rate (CAGR) of 27.18%. Oncology Biosimilars Market Global Briefing 2022 provides strategists, marketers and senior manage ... Read More
-
Biosimilars Global Market Opportunities And Strategies To 2031
Biosimilars Global Market Opportunities And Strategies To 2031 Biosimilars Global Market Opportunities And Strategies To 2031 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global biosimilars market a ... Read More
-
Biosimilars Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change
Biosimilars Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change Biosimilars Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change from The Business Research Company provides the strategists; marketers and senior management with the critical informa ... Read More
-
Pegfilgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change Including: 1) By Application: Chemotherapy Induced Neutropenia; Transplantation; Others 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Mail-Order Pharmacies Covering: Coherus BioSciences; Biocon/Mylan; Sandoz (Novartis); Intas Biopharmaceuticals Ltd.; Mundipharma GmbH
Pegfilgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global pegfilgrastim biosimilars market as it em ... Read More
Research Assistance
